{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:44:55Z","timestamp":1762865095447},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[1999,9,1]],"date-time":"1999-09-01T00:00:00Z","timestamp":936144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>We assessed the associations of eight bone turnover markers (BTMs) with baseline and 1-year percentage changes in lumbar spine and hip bone mineral density (BMD) of 293 postmenopausal women undergoing treatment with hormone replacement therapy (HRT) or placebo using squared correlation coefficients (R2). In 239 women assigned to treatment with estrogen alone or with with estrogen plus progestins (active treatment), mean percentage changes for all markers decreased significantly and remained below baseline values through 3 years of study, whereas mean percentage changes for 54 women assigned to the placebo group showed no significant change from baseline in any marker. At baseline, age and body mass index (BMI) together accounted for 16% and 25% of the variance in spine and hip BMD, respectively. The telopeptide resorption marker, cross-linked N-telopeptide of type I collagen (NTX), alone accounted for 12% and 8% of variance, respectively. Another telopeptide, carboxy-terminal telopeptide of type I collagen (Crosslaps), accounted for 8% and 7% of variance, respectively. A bone-specific alkaline phosphatase (BALP-2) accounted for 8% of variance at the spine and 5% at the hip. No other marker accounted for more than 5% of total variance at either site; adding either baseline NTX, Crosslaps, or BAP-2 to regressions containing age and BMI increased R2 values at the spine and hip to about 22% and 28%, respectively. In the placebo group, baseline spine BMD accounted for 4% of the variance in 1-year spine BMD percentage change, whereas baseline values for age and BMI accounted for 1% and 0% of the variance, respectively; none of the three accounted for more than 0% of hip BMD percentage change; Crosslaps and NTX contributed 5% and 4% to the variance in 1-year spine BMD percentage change, but other markers accounted for &amp;lt; 2% of variance at the spine. At the hip, another BALP (BALP-1) accounted for 4% of variance, but no other baseline marker except NTX accounted for more than 1% of variance. In the active treatment group, baseline values for age, BMI, and spine BMD together accounted for 13% of the percentage change in spine BMD and for 4% of the BMD change at the hip. No individual or pair of baseline markers significantly enhanced these R2 values, but addition of 1-year percentage changes in some individual markers did significantly increase it. The largest R2 value was obtained by adding the percentage change in BALP-2, which increased the R2 in spine BMD percentage change to 20% and that at the hip to 8%. Adding baseline and change variables for all eight markers to the regression increased R2 to 28% at the spine and 12% at the hip. Restricting the set of analyses to individuals who suppressed marker activity beyond the precision error for the measurement did not improve R2s for the regressions. When baseline marker values were stratified into quartiles, only NTX and osteocalcin showed significant relationships between quartile and change in spine BMD, and these did not reach significance at the hip. When the 1-year change in markers was stratified into quartiles, significant relationships with percentage change in spine BMD were observed only for BALP phosphatases. We conclude that BTMs are not a surrogate for BMD to identify women with low bone mass and that they offer little useful information for predicting BMD changes for individual untreated or HRT-treated postmenopausal women.<\/jats:p>","DOI":"10.1359\/jbmr.1999.14.9.1583","type":"journal-article","created":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T01:34:54Z","timestamp":1146101694000},"page":"1583-1595","source":"Crossref","is-referenced-by-count":90,"title":["The Relationship of Biochemical Markers of Bone Turnover to Bone Density Changes in Postmenopausal Women: Results from the Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial"],"prefix":"10.1093","volume":"14","author":[{"given":"Robert","family":"Marcus","sequence":"first","affiliation":[{"name":"Department of Medicine, Stanford University and the Geriatrics Research, Education & Clinical Center, Veterans Affairs Medical Center, Palo Alto, California, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah","family":"Holloway","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University and the Geriatrics Research, Education & Clinical Center, Veterans Affairs Medical Center, Palo Alto, California, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley","family":"Wells","sequence":"additional","affiliation":[{"name":"Biostatistics Section, Department of Public Health Sciences, Wake Forest University School of Medicine, Winston Salem, North Carolina, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail","family":"Greendale","sequence":"additional","affiliation":[{"name":"Department of Medicine, UCLA School of Medicine, Los Angeles, California, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret K.","family":"James","sequence":"additional","affiliation":[{"name":"Biostatistics Section, Department of Public Health Sciences, Wake Forest University School of Medicine, Winston Salem, North Carolina, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Wasilauskas","sequence":"additional","affiliation":[{"name":"Biostatistics Section, Department of Public Health Sciences, Wake Forest University School of Medicine, Winston Salem, North Carolina, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Kelaghan","sequence":"additional","affiliation":[{"name":"Contraception & Reproductive Health Branch, National Institute of Child Health & Development, National Institutes of Health, Bethesda, Maryland, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,12,2]]},"reference":[{"key":"2024020713353465500_bib1","first-page":"1075","volume-title":"Osteoporosis","author":"Delmas","year":"1996"},{"key":"2024020713353465500_bib2","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/0197-2456(94)00033-Y","article-title":"Rationale, design, and conduct of the PEPI Trial","volume":"16","author":"The Postmenopausal Estrogen\/Progestin Interventions, (PEPI) Trial Investigators","year":"1995","journal-title":"Control Clin Trials"},{"key":"2024020713353465500_bib3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","article-title":"Effects of estrogen\/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial","volume":"273","author":"The Postmenopausal Estrogen\/Progestin Interventions, (PEPI) Trial Investigators","year":"1995","journal-title":"JAMA"},{"key":"2024020713353465500_bib4","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/jbmr.5650090920","article-title":"Correlates of bone mineral density in the Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial","volume":"9","author":"Marcus","year":"1994","journal-title":"J Bone Miner Res"},{"key":"2024020713353465500_bib5","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/jama.1996.03540170033029","article-title":"Effects of hormone therapy on bone mineral density: Results from the Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial","volume":"276","author":"The Writing Group for the PEPI Trial","year":"1996","journal-title":"JAMA"},{"key":"2024020713353465500_bib6","volume-title":"SAS\/STAT User's Guide, Version 6","author":"SAS, Institute Inc.","year":"1989","edition":"4th Ed."},{"key":"2024020713353465500_bib7","first-page":"366","article-title":"The short term effects of conjugated estrogen on bone turnover in older women","volume":"79","author":"Prestwood","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020713353465500_bib8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1359\/jbmr.1998.13.2.297","article-title":"Rapid bone loss is associated with increased levels of biochemical markers","volume":"13","author":"Ross","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2024020713353465500_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0002-9343(96)00387-7","article-title":"Hormone replacement therapy in postmenopausal women: Urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density","volume":"102","author":"Chesnut","year":"1997","journal-title":"Am J Med"},{"key":"2024020713353465500_bib10","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1359\/jbmr.1998.13.9.1431","article-title":"Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in in representative elderly women: a randomized clinical trial","volume":"13","author":"Greenspan","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2024020713353465500_bib11","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1359\/jbmr.1997.12.4.624","article-title":"The usefulness of bone turnover in predicting the response to transdetmal estrogen therapy in postmenopausal osteoporosis","volume":"12","author":"Gonnelli","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2024020713353465500_bib12","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/clinchem\/43.9.1570","article-title":"Comparison of analytical performance and biological variability of three bone resorption assays","volume":"43","author":"Ju","year":"1997","journal-title":"Clin Chem"},{"key":"2024020713353465500_bib13","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1359\/jbmr.1998.13.7.1124","article-title":"Response of biochemical markers of bone turnover to hormone replacement therapy: Impact of biological variability","volume":"13","author":"Hannon","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2024020713353465500_bib14","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-4477-1","volume-title":"Measurement Error in Nonlinear Models","author":"Caroll","year":"1995"},{"key":"2024020713353465500_bib15","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/jbmr.5650111021","article-title":"Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study","volume":"11","author":"Garnero","year":"1996","journal-title":"J Bone Miner Res"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.1999.14.9.1583","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/14\/9\/1583\/56599474\/5650140914.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/14\/9\/1583\/56599474\/5650140914.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:58:58Z","timestamp":1710341938000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/14\/9\/1583-1595\/7514802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,9,1]]},"references-count":15,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2009,12,2]]},"published-print":{"date-parts":[[1999,9,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.1999.14.9.1583","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1999,9,1]]},"published":{"date-parts":[[1999,9,1]]}}}